 |
|
|
| |
Cardiovascular Disease Risk Assessments and Fasting Lipid Changes in Virologically Suppressed Patients Randomized to Switch to Tenofovir
Alafenamide versus Continuing Tenofovir Disoproxil Fumarate
|
| |
| |
22nd International AIDS Conference (AIDS 2018), Amsterdam, Netherlands, 23-27 July 2018
Oral TUPEB104
Download the PDF here
Chloe Orkin,1 Francesco Castelli,2 Yazdan Yazdanpanah,3 Jurgen
Rockstroh,4 Cynthia Brinson,5 Giovanni DiPerri,6 Ya-Pei Liu,7 Lijie
Zhong,7 Sean E. Collins,7 Hal Martin,7 Devi SenGupta,7 Moupali Das7
1Grahame Hayton Unit, Royal London Hospital, London, UK; 2University of Brescia and Spedali Civili General Hospital, Brescia, Italy; 3Hopital Bichat Claude Bernard, Paris, France; 4University Hospital Bonn, Germany; 5Central Texas Clinical Research, Austin, TX; 6University of Torino, Italy; 7Gilead Sciences, Inc., Foster City, California, USA
References
1. Hadigan C, et al. JAMA Cardiol 2017;2:123-4;
2. Arribas JR, et al. J Acquir Immune Defic Syndr. 2017; 75:211-8;
3. Santos JR, et al. Clin Infect Dis 2015;61(3):403-8;
4. Orkin C, et al. Lancet HIV. 2017; 4:e195-e204;
5. Raffi F, et al. J Acquir Immune Defic Syndr. 2017; 75:226-31;
6. Goff DC, et al. Circulation
2014;129(Suppl 2):S49-S73;
7. Stone NJ, et al. Circulation 2014;129(Suppl 2):S76-S99;
8. Feinstein MJ, et al. JAMA Cardiology 2017;2(2):155-162.
doi:10.1001/jamacardio.2016.4494;
9. European AIDS Clinical Society (EACS) Guidelines Version 9.0. October 2017.
http://www.eacsociety.org/guidelines/eacsguidelines/
eacs-guidelines.html. Accessed 6 June 2018;
10. US Preventive Services Task Force. JAMA 2016;316(19):1997-2007; 11. D:A:D Study Group, Smith C. AIDS 2010;24:1537-48; 12. Elion RA, et al. JAIDS 2018;78:62-72.
|
| |
|
|
|
|
|
